Boston Scientific Eluvia Drug-Eluting Stent Demonstrates Superior Results In IMPERIAL Trial
Boston Scientific Eluvia Drug-Eluting Stent Demonstrates Superior Results In IMPERIAL Trial

Today, Boston Scientific (NYSE: BSX) announced positive 12-month data from the IMPERIAL trial, the first head-to-head drug-eluting stent trial in the superficial femoral artery (SFA). Results were presented during a...

Digital Transformation in the Pharmaceuticals Industry-Companies-to-Action, 2018 - Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
Digital Transformation in the Pharmaceuticals Industry-Companies-to-Action, 2018 - Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Sept 21, 2018 /PRNewswire/ -- The "Digital Transformation in the Pharmaceuticals Industry-Companies-to-Action, 2018" report has been a...

AlloSource Named One Of The 100 Healthiest Workplaces In America By Healthiest Employers
AlloSource Named One Of The 100 Healthiest Workplaces In America By Healthiest Employers

AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in...

Global DNA Vaccine Market Outlook 2018-2022: Increasing Investment, Dramatic Increase in Chronic Disorders, Strong DNA Vaccine Pipeline & Technological Advancements
Global DNA Vaccine Market Outlook 2018-2022: Increasing Investment, Dramatic Increase in Chronic Disorders, Strong DNA Vaccine Pipeline & Technological Advancements

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Sept 21, 2018 /PRNewswire/ -- The "Global DNA Vaccine Market Outlook 2022" report has been added to ResearchAndMarkets.com's offer...

Abingworth Appoints Brian Gallagher, Jr
Abingworth Appoints Brian Gallagher, Jr

Abingworth, the international investment group dedicated to life sciences, today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company's Boston office. Brian has more than 20 years...

Sensus Healthcare, Inc. Announces Underwriters' Exercise of Option
Sensus Healthcare, Inc. Announces Underwriters' Exercise of Option

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise in full of the underwriters' option received in connection with...

Global DNA Vaccine Market Outlook 2018-2022: Increasing Investment, Dramatic Increase in Chronic Disorders, Strong DNA Vaccine Pipeline & Technological Advancements
Global DNA Vaccine Market Outlook 2018-2022: Increasing Investment, Dramatic Increase in Chronic Disorders, Strong DNA Vaccine Pipeline & Technological Advancements

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Sept 21, 2018 /PRNewswire/ -- The "Global DNA Vaccine Market Outlook 2022" report has been added to ResearchAndMarkets.com's offer...

Abingworth Appoints Brian Gallagher, Jr
Abingworth Appoints Brian Gallagher, Jr

Abingworth, the international investment group dedicated to life sciences, today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company's Boston office. Brian has more than 20 years...

Sensus Healthcare, Inc. Announces Underwriters' Exercise of Option
Sensus Healthcare, Inc. Announces Underwriters' Exercise of Option

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise in full of the underwriters' option received in connection with...

Japan Pharmaceutical Firm Sales Practices Report 2018: Current Sales Activities, Regulations, Issues, and Suggested Methodologies
Japan Pharmaceutical Firm Sales Practices Report 2018: Current Sales Activities, Regulations, Issues, and Suggested Methodologies

The "Japanese Sales Practices at Pharmaceutical Firms - 2018" report has been added to ResearchAndMarkets.com's offering. This report discusses about the general sales practices at pharmaceutical firms in Japan. The...

Population Health Initiative To Pioneer Sustainable Community Influenza Vaccination Models For Underserved, Older Adults
Population Health Initiative To Pioneer Sustainable Community Influenza Vaccination Models For Underserved, Older Adults

Sustainable Healthy Communities (SHC), a wholly owned subsidiary of the National Minority Quality Forum (NMQF), today announced a new population health initiative aimed at improving patient outcomes in underserved...

ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide
ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide

Today, the Medical Technology business group of ZEISS announced two milestones in refractive technology after  the  recent  completion  of  1.5  million  treatments with SMILE® and the production of its 1,000th VisuMax®...

Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults
Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults

Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Emgality™ (galcanezumab) for the...

Pharmacovigilance: 3-Day Course (London, United Kingdom - December 3-5, 2018)
Pharmacovigilance: 3-Day Course (London, United Kingdom - December 3-5, 2018)

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Sept 21, 2018 /PRNewswire/ -- The "Pharmacovigilance" conference has been added to ResearchAndMarkets.com's offering. This course...

AbbVie Receives Positive CHMP Opinion for a Novel, Chemotherapy-free Combination of VENCLYXTO® (venetoclax tablets) with Rituximab as a Treatment with a Fixed Duration for Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior The
AbbVie Receives Positive CHMP Opinion for a Novel, Chemotherapy-free Combination of VENCLYXTO® (venetoclax tablets) with Rituximab as a Treatment with a Fixed Duration for Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior The

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion...

European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma
European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma

Array BioPharma Inc. (NASDAQ: ARRY) today announced that the European Commission (EC) has approved BRAFTOVI® in combination with MEKTOVI® for the treatment of adult patients with unresectable or metastatic melanoma with a...

Global Pharmaceutical Packaging Market 2018-2023 with Sonoco Products Company, Amcor Group, West Pharmaceutical Services, Inc. and IntraPac International Dominating
Global Pharmaceutical Packaging Market 2018-2023 with Sonoco Products Company, Amcor Group, West Pharmaceutical Services, Inc. and IntraPac International Dominating

The "Global Pharmaceutical Packaging Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical Packaging Market was valued at US$71.379 billion in...

Swap Drugs for Sportswear - Workout is the New High
Swap Drugs for Sportswear - Workout is the New High

Last week, a revolutionary pop-up shop opened in central Amsterdam, where people could swap drugs for sportswear. Why? Because you don't need drugs to get high – the same feel-good substances are released in your brain...

Global Memristor Market 2018 to 2023 - Focus on Analog, Memory, Digital & Neuromorphic Applications
Global Memristor Market 2018 to 2023 - Focus on Analog, Memory, Digital & Neuromorphic Applications

The "Memristor Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. Memristor market was valued at US$12.693 million in 2017 and is projected to expand at a CAGR of 57.19%...

Health Information Exchange (NEHII) and CareRise® Holdings Announce Alliance to Promote HI-TECH Care Transition Software To Acute and Post-Acute Healthcare Facilities Throughout The State of Nebraska
Health Information Exchange (NEHII) and CareRise® Holdings Announce Alliance to Promote HI-TECH Care Transition Software To Acute and Post-Acute Healthcare Facilities Throughout The State of Nebraska

CareRise® Holdings and the State of Nebraska's Health Information Exchange, 'NEHII' Nebraska Health Information Initiative, have announced an alliance to promote CareRise's latest care-transition software...

Connect 

BTG Announces Global Launch of the ICEfx™ Cryoablation System
BTG Announces Global Launch of the ICEfx™ Cryoablation System

The ICEfx™ Cryoablation system is a compact and powerful console, offering predictable, reliable performance with seamless therapy delivery and exceptional ease of technical operation BTG plc (LSE: BTG), a global...

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology

Innovent Biologics (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data on cohort D of sintilimab clinical studies at the...

Clarius Awards $250,000 Worth of Advanced Ultrasound Technology to Four Medical Schools
Clarius Awards $250,000 Worth of Advanced Ultrasound Technology to Four Medical Schools

Clarius Mobile Health announced the recipients for the Medical School Award (MSA) over the weekend, due to the cancellation of this year's World Congress of Ultrasound in Medical Education (WCUME). The program received...

The global bioinformatics market is projected to grow at a CAGR of 14.5%
The global bioinformatics market is projected to grow at a CAGR of 14.5%

The global bioinformatics market is projected to grow at a CAGR of 14.5%. The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for...

Digital Transformation in the Pharmaceuticals Industry-Companies-to-Action, 2018
Digital Transformation in the Pharmaceuticals Industry-Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities Read the full report: https://www.reportlinker.com/p05567615 The pharmaceutical industry today is in a...

MedNet Solutions' Kelly Ritch to Present at Society for Clinical Data Management (SCDM) Annual Conference
MedNet Solutions' Kelly Ritch to Present at Society for Clinical Data Management (SCDM) Annual Conference

MedNet Solutions, an e-clinical software provider, announced today that Kelly Ritch, vice president of strategic partnerships, will present in three different panel sessions at SCDM 2018 Annual Conference.  The three...

Juntendo University Research: The Genetics of Muscle Injuries
Juntendo University Research: The Genetics of Muscle Injuries

To test whether sex-related genetic polymorphisms are associated with muscle injury and stiffness, Noriyuki Fuku from Juntendo University and colleagues report in the journal Medicine & Science in Sports & Exercise...

Dr. Briggs Cook Jr., is Named the Leading Provider of QuickLift® Face Lift
Dr. Briggs Cook Jr., is Named the Leading Provider of QuickLift® Face Lift

With a wealth of experience in the medical field, numerous credentials, and over 50 published medical articles under his belt, Dr. Briggs Cook Jr has become the leading provider of QuickLift®, an innovative facelift...

SIFFA: Latvia’s Health Care Reforms a Step in the Right Direction but Need Continued Support and Increased Financing
SIFFA: Latvia’s Health Care Reforms a Step in the Right Direction but Need Continued Support and Increased Financing

International pharmaceutical companies represented in Latvia welcome the progress achieved in implementing the health care reform and strongly support its continuation.  "After quite some time, this year for the health...

Health Canada Approves Ipsen's CABOMETYX™ (cabozantinib) Giving Physicians and Patients a Novel Second-Line Option in the Fight Against Advanced Renal Cell Carcinoma
Health Canada Approves Ipsen's CABOMETYX™ (cabozantinib) Giving Physicians and Patients a Novel Second-Line Option in the Fight Against Advanced Renal Cell Carcinoma

CABOMETYX™ is the first and only single agent to demonstrate statistically significant clinical benefits across three key efficacy endpoints of overall survival (OS), progression free survival (PFS) and objective response...

After Sun Care Products Market Size Worth $2.81 Billion by 2025: Grand View Research, Inc.
After Sun Care Products Market Size Worth $2.81 Billion by 2025: Grand View Research, Inc.

The global after sun care products market size is estimated to reach USD 2.81 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.1% during the forecast period. Rising product...

I-Mab Wins Frost & Sullivan "2018 Best R&D Innovator Award (Biopharma Category)"
I-Mab Wins Frost & Sullivan "2018 Best R&D Innovator Award (Biopharma Category)"

I-Mab Biopharma ("I-Mab") announced today that it has been recognized by Forest & Sullivan, the global leading growth consulting company as well as the biggest growth consulting company in China, with the "2018 Best...

US News 

Local News 

World News